Oncotarget published this trending research perspective in Volume 12, Issue 25, entitled, "Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects" by Yuri Lazebnik, PhD., from Lerna Consulting, New Haven, CT. Abstract: A distinctive feature of the SARS-CoV-2 spike protein is its ability to efficiently fuse cells, thus producing syncytia found in COVID-19 patients. This commentary proposes how this ability enables spike to cause COVID-19 complications as well as side effects of COVID-19 vaccines, and suggests how these effects can be prevented. Press release - https://www.oncotarget.com/news/pr/sars-cov-2-covid-19-vaccine-side-effects/ Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28088 DOI - https://doi.org/10.18632/oncotarget.28088 Full text - https://www.oncotarget.com/article/28088/text/ Correspondence to - Yuri Lazebnik - yuri@lernaconsulting.com Keywords - cell fusion, thrombosis, neuropathy, cancer, vaccines About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/c/OncotargetYouTube/ LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957
Cancer ResearchChemistryMicrobiologyMolecular Biology